Table 7 Characteristics of the Finnish and Spanish recipients.
Characteristic | Finnish recipients* | Spanish recipients† | P |
|---|---|---|---|
Recipient age, median years (range) | 49 (18–65) | 50 (8–72) | 0.085‡ |
Donor age, median years (range) | 46 (4–65) | 47 (3–78) | 0.424‡ |
Recipient-donor gender, n (%) | |||
Male-male | 73 (28) | 87 (33) | 0.479§ |
Male-female | 57 (22) | 62 (23) | |
Female-female | 61 (23) | 51 (19) | |
Female-male | 71 (27) | 66 (25) | |
Diagnosis, n (%) | |||
Acute myeloid leukemia | 73 (28) | 88 (33) | 0.203§ |
Acute lymphoblastic leukemia | 39 (15) | 24 (9) | 0.036§ |
Chronic myeloid leukemia | 37 (14) | 13 (5) | <0.001§ |
Myelodysplastic syndrome | 20 (8) | 26 (10) | 0.390§ |
Hodgkin’s lymphoma | 0 (0) | 12 (5) | 0.001§ |
Non-Hodgkin’s lymphoma | 12 (5) | 50 (19) | <0.001§ |
Myeloma | 56 (21) | 38 (14) | 0.032§ |
Aplastic anemia | 4 (2) | 5 (2) | 1.000|| |
Other malignancies | 21 (8) | 11 (4) | 0.060§ |
Stem cell source, n (%) | |||
Bone marrow | 138 (53) | 13 (5) | <0.001§ |
Peripheral blood | 124 (47) | 254 (95) | |
Conditioning regimen, n (%) | |||
Myeloablative | 199 (76) | 110 (42) | <0.001§ |
Reduced intensity conditioning | 63 (24) | 151 (58) | |
aGvDH grades III–IV, n (%) | 23 (11) | 39 (18) | 0.044§ |
cGvHD, extensive, n (%) | 71 (39) | 54 (32) | 0.156§ |
